Voxelotor (Oxbryta®) will be administered in the form of a tablet taken once a day for eligible patients and could help reduce the need for blood transfusions and lead to fewer hospital appointments.
More than 57,000 new and expectant mums have received specialist support for mental health problems over the last year, up a third on 2022, NHS figures show. Every part of England now has a specialist ...